Implementation of a drug-use and disease-state management program

被引:19
作者
Skledar, SJ
Hess, MM
机构
[1] Univ Pittsburgh, Med Ctr Hlth Syst, Drug Use & Dis State Management Program, Pittsburgh, PA USA
[2] Univ Pittsburgh, Sch Pharm, Pittsburgh, PA USA
[3] Univ Pittsburgh, Sch Family Med, Pittsburgh, PA USA
关键词
administration; clinical pharmacists; compliance; computers; costs; disease management; drug use; drugs; adverse reactions; errors; medication; guidelines; hospitals; pharmaceutical services; pharmacists; hospital; pharmacy; institutional; physicians; prescribing; professional competence; protocols; quality assurance; surgical wound infection;
D O I
10.1093/ajhp/57.suppl_4.S23
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A drug-use and disease-state management (DUDSM) program was instituted in 1996 at a teaching hospital associated with a large nonprofit health care system. The program's goals are to optimize pharmacotherapeutic regimens, evaluate health outcomes of identified disease states, and evaluate the economic impact of pharmacotherapeutic options for given disease states by developing practice guidelines. Through a re-engineering process, resources within the pharmacy department were identified that could be devoted to the DUDSM program, including the use of clinical pharmacy specialists, promotion of staff pharmacists into the DUDSM program, a pharmacy technician, and information systems support. A strength of the program is its systematic approach for developing and implementing new initiatives, as well as monitoring compliance with all initiatives on an ongoing basis. The initiative-design process incorporates continuous quality improvement principles, outcome design and evaluation, competency assessment for all pharmacists, multidisciplinary collaboration, and sophisticated information systems. Seventy-five initiatives have been implemented, ranging from simple dose-optimization strategies for specific drugs to complicated practice guidelines for managing specific disease states. Improved patient outcomes have been documented, including reduced length of stay, postsurgical wound infection, adverse drug reactions, and medication errors. Documented cost savings exceeded $4 million annually for fiscal years 1996-97 through 1999-2000. Overall compliance with DUDSM initiatives exceeds 80%, and physician service profiling has been initiated to monitor variant prescribing. The DUDSM program has successfully integrated practice guidelines into therapeutic decision-making, resulting in improved patient-care outcomes and cost savings.
引用
收藏
页码:S23 / S29
页数:7
相关论文
共 4 条
[1]   Why don't physicians follow clinical practice guidelines? A framewouk for improvement [J].
Cabana, MD ;
Rand, CS ;
Powe, NR ;
Wu, AW ;
Wilson, MH ;
Abboud, PAC ;
Rubin, HR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (15) :1458-1465
[2]   Evidence-based disease management [J].
Ellrodt, G ;
Cook, DJ ;
Lee, J ;
Cho, M ;
Hunt, D ;
Weingarten, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (20) :1687-1692
[3]   From outcomes research to disease management: A guide for the perplexed [J].
Epstein, RS ;
Sherwood, LM .
ANNALS OF INTERNAL MEDICINE, 1996, 124 (09) :832-837
[4]  
Johnson N, 1998, FORMULARY, V33, P665